{
    "clinical_study": {
        "@rank": "25098", 
        "acronym": "BANNISTER", 
        "arm_group": [
            {
                "arm_group_label": "Salbutamol - Placebo", 
                "arm_group_type": "Experimental", 
                "description": "salbutamol at M0 and M60 placebo administration"
            }, 
            {
                "arm_group_label": "Placebo - Salbutamol", 
                "arm_group_type": "Experimental", 
                "description": "placebo at M0 and M60 salbutamol administration"
            }
        ], 
        "brief_summary": {
            "textblock": "randomized double-blind controlled study in parallel groups"
        }, 
        "brief_title": "Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Clinically Significant Increase in Maximum Expiratory Volume Per Second", 
        "condition_browse": {
            "mesh_term": "Respiratory Insufficiency"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient over 18 years old\n\n          -  Patient with BPCO, defined:\n\n               -  by an irreversible obstructive syndrome\n\n               -  and\\or by different arguments (histories, symptoms, physical examination,\n                  thoracic radiography, gas of the blood)\n\n          -  Decompensation of this BPCO in the form of acute respiratory failure\n\n          -  No argument for a dominant acute left cardiac insufficiency\n\n          -  Consent signed by the patient\n\n          -  Patient with national health assurance\n\n        Exclusion Criteria:\n\n          -  Contraindications in the not invasive ventilation\n\n          -  Patient not volunteer for the realization of the spirometry\n\n          -  Precautions for use of \u00df2 mimetic (engrave hyperthyroidism)\n\n          -  Under guardianship patient or protection of justice\n\n          -  Pregnant patient"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "68", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01958814", 
            "org_study_id": "PHAO11-PD / BANNISTER", 
            "secondary_id": "2011-004802-20"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Salbutamol - Placebo", 
                    "Placebo - Salbutamol"
                ], 
                "intervention_name": "Salbutamol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Salbutamol - Placebo", 
                    "Placebo - Salbutamol"
                ], 
                "intervention_name": "Placebo : physiological serum", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Albuterol"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 8, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Thierry BOULAIN, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Orl\u00e9ans", 
                        "country": "France", 
                        "zip": "45000"
                    }, 
                    "name": "Service de R\u00e9animation M\u00e9dicale - CHR d'Orl\u00e9ans"
                }, 
                "investigator": {
                    "last_name": "Thierry BOULAIN, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "dequin@med.univ-tours.fr", 
                    "last_name": "Pierre-Fran\u00e7ois DEQUIN", 
                    "phone": "02.47.47.84.45"
                }, 
                "facility": {
                    "address": {
                        "city": "Tours", 
                        "country": "France", 
                        "zip": "37000"
                    }, 
                    "name": "CHRU de Tours"
                }, 
                "investigator": {
                    "last_name": "Pierre-Fran\u00e7ois DEQUIN, MD - PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Controlled Randomized Double-blind Study Comparing Salbutamol and Placebo Via Aerosol in Chronic Obstructive Respiratory Insufficiency in Exacerbartion Treated With Noninvasive Ventilation", 
        "overall_contact": {
            "email": "dequin@med.univ-tours.fr", 
            "last_name": "Pierre-Fran\u00e7ois DEQUIN, MD-PhD", 
            "phone": "02.47.47.84.45"
        }, 
        "overall_contact_backup": {
            "email": "marie.coudray@med.univ-tours.fr", 
            "last_name": "Marie COUDRAY", 
            "phone": "02.47.47.46.64"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Collection at the bedside spirometric values\u200b\u200b", 
            "safety_issue": "No", 
            "time_frame": "gross change in forced expiratory volume in one second from the beginning of salbutamol or placebo and 15 min after the start"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01958814"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "gross change in vital capacity of peak expiratory flow rate, the ratio of FEV, forced expiratory flow", 
                "safety_issue": "No", 
                "time_frame": "between the median baseline and 15 min after the start of treatment"
            }, 
            {
                "measure": "gross change in respiratory rate, heart rate and systolic and diastolic blood pressure", 
                "safety_issue": "No", 
                "time_frame": "between baseline and 15 min after the start of treatment"
            }, 
            {
                "measure": "gross change in dyspnea", 
                "safety_issue": "No", 
                "time_frame": "between baseline and 15 min after the start of treatment"
            }
        ], 
        "source": "University Hospital, Tours", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Tours", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}